A Phase 3 Study to Compare Between CT-P41 and US-licensed Prolia in Postmenopausal Women With Osteoporosis

NCT04757376 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
479
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Celltrion